These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8146182)

  • 1. Protein S binds to and inhibits factor Xa.
    Heeb MJ; Rosing J; Bakker HM; Fernandez JA; Tans G; Griffin JH
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2728-32. PubMed ID: 8146182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C.
    Heeb MJ; Mesters RM; Tans G; Rosing J; Griffin JH
    J Biol Chem; 1993 Feb; 268(4):2872-7. PubMed ID: 8428962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
    Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
    Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
    Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
    J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.
    Hackeng TM; van 't Veer C; Meijers JC; Bouma BN
    J Biol Chem; 1994 Aug; 269(33):21051-8. PubMed ID: 8063724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155-->Glu) for the regulation of the blood coagulation system.
    Hayashi T; Nishioka J; Suzuki K
    Biochim Biophys Acta; 1995 Dec; 1272(3):159-67. PubMed ID: 8541347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human protein S cleavage and inactivation by coagulation factor Xa.
    Long GL; Lu D; Xie RL; Kalafatis M
    J Biol Chem; 1998 May; 273(19):11521-6. PubMed ID: 9565566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation factor Xa interacts with a linear sequence of the kringle 2 domain of prothrombin.
    Taneda H; Andoh K; Nishioka J; Takeya H; Suzuki K
    J Biochem; 1994 Sep; 116(3):589-97. PubMed ID: 7852276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C.
    Mesters RM; Heeb MJ; Griffin JH
    Protein Sci; 1993 Sep; 2(9):1482-9. PubMed ID: 8401232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.
    Deguchi H; Sinha RK; Marchese P; Ruggeri ZM; Zilberman-Rudenko J; McCarty OJT; Cohen MJ; Griffin JH
    Blood; 2016 Oct; 128(14):1870-1878. PubMed ID: 27421960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of human factors X and Xa to HepG2 and J82 human tumor cell lines. Evidence that factor Xa binds to tumor cells independent of factor Va.
    Sakai T; Kisiel W
    J Biol Chem; 1990 Jun; 265(16):9105-13. PubMed ID: 2160956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of venom phospholipases: the strongly anticoagulant phospholipase A(2) from Naja nigricollis venom binds to coagulation factor Xa to inhibit the prothrombinase complex.
    Kerns RT; Kini RM; Stefansson S; Evans HJ
    Arch Biochem Biophys; 1999 Sep; 369(1):107-13. PubMed ID: 10462445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.
    Heeb MJ; Prashun D; Griffin JH; Bouma BN
    FASEB J; 2009 Jul; 23(7):2244-53. PubMed ID: 19244162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
    Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
    J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular interaction site on procoagulant myosin for factor Xa-dependent prothrombin activation.
    Deguchi H; Guo Z; Hayat M; Pflimlin E; Lear S; Shen W; Griffin JH
    J Biol Chem; 2019 Oct; 294(41):15176-15181. PubMed ID: 31481465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.